Biora Therapeutics Inc.

NASDAQ: PROG · Real-Time Price · USD
0.88
-0.04 (-3.96%)
At close: May 09, 2022, 6:00 AM

Biora Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.35M 25.77M 39.45M 65.21M 82.01M
Cost of Revenue
n/a 22.23M 43.66M 67.26M 89.1M
Gross Profit
1.35M 3.54M -4.21M -2.05M -7.09M
Operating Income
-173.62M -203.3M -163.83M -177.84M -188.91M
Interest Income
3.37M 18.22M 18.22M 17.75M 14.85M
Pretax Income
-160.87M -178.64M -185.9M -196.09M -207.48M
Net Income
-201.99M -222.52M -230.07M -233.39M -207.64M
Selling & General & Admin
49.89M 73.3M 111.09M 126.45M 133.65M
Research & Development
40.67M 45.78M 48.53M 49.34M 48.18M
Other Expenses
n/a n/a n/a n/a n/a
Operating Expenses
90.56M 119.08M 159.62M 175.79M 181.82M
Interest Expense
6.36M 12.64M 34.47M 33.51M 36.07M
Selling & Marketing Expenses
-9.89M 4.76M 29.7M 42.37M 53.1M
Cost & Expenses
90.56M 141.32M 203.28M 243.05M 270.92M
Income Tax Expense
-7.98M -5.22M -4.94M -2.08M 164K
Shares Outstanding (Basic)
183.2M 166.07M 95.85M 63.94M 57.49M
Shares Outstanding (Diluted)
183.2M 166.07M 95.85M 63.94M 57.49M
EPS (Basic)
-2.16 -2.66 -3.78 -4.33 -9.18
EPS (Diluted)
-2.16 -2.66 -3.78 -4.33 -9.18
EBITDA
-222.21M -233.46M -193.07M -196.19M -166.8M
EBIT
-154.51M -166M -151.43M -162.58M -171.41M
Depreciation & Amortization
510K 1.44M 2.36M 3.52M 4.61M